AXGN

#4287
Axogen, Inc. - Common Stock
0.3 9 USD
-99.02%
Sektör: Sağlık Hizmetleri
Baz: USD
Kar Para Birimi: USD
Günlük Aralık
0.39
0.39
Yıllık Aralık
0.39
45.75
Günlük Değişim
-99.02%
Aylık Değişim
-99.07%
6 Aylık Değişim
-98.64%
Yıllık Değişim
-97.84%
Önceki Kapanış
40.4 2
Open
0.3 9
Düşük
0.3 9
High
0.3 9
Hacim
121
Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler Temettüler
Çeyreklik Yıllık
  • Market Capitalization 20.99 M
  • Employee 622
  • Founded 2002
  • CEO N/A
  • Website www.axogeninc.com
  • Headquarter Minnesota, United States
  • FIGI BBG000BN46R9
  • Industry Tıbbi Cihazlar
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-96.26
Fiyat/satışlar oranı
6.69

Axogen, Inc. - Common Stock

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator. As of 2019, Axogen was the only commercially available allograft approved by the Food and Drug Administration for clinical use.

Haberler